LOGM 51.86 Logmein Inc $LOGM Hit a 52 week high of 52.03

New Post Public Reply Private Reply Replies (0) Message Board

Nov 13, 2014 at 12:45 PM

LOGM 51.86 Logmein Inc $LOGM Hit a 52 week high of 52.03 Closing the day 09:45 at 51.86 +0.25 +0.48% With a day low of 51.66 and a total volume of 17,420.

LOGM Recent Posts: http://investorshangout.com/LogMeIn-Inc-LOGM-54654/

LOGM Logmein Inc Recent Headline News

CACI International Secures $32.5M US Army Contract - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 6:07PM CST
CACI International Inc (CACI) recently secured a $32.5 million contract to support the development of sensor technologies for the U.S. Army???s Night Vision and Electronic Sensors Directorate (NVESD).
CARB: 11.63 (+0.22), LOGM: 51.74 (+0.13), CACI: 86.31 (+0.44), NCIT: 10.65 (-0.30)

CACI, JIEDDO Team Up to Counter Improvised Explosives - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 5:30PM CST
CACI International (CACI) secured a task order potentially worth $149 million, under which it will deploy operations/intelligence integration teams to aid U.S. Defense in combating improvised explosive devices.
CARB: 11.63 (+0.22), LOGM: 51.74 (+0.13), CACI: 86.35 (+0.48), NCIT: 10.65 (-0.30)

LogMeIn to Underscore Importance of Mobile Customer Engagement at Contact Center Demo & Conference
GlobeNewswire - Wed Nov 05, 8:08AM CST
LogMeIn, Inc.'s (Nasdaq:LOGM) Ross Haskell will be a featured speaker at this week's Contact Center Demo & Conference, taking place at the Hyatt Regency Chicago from Nov. 5-7, 2014. Haskell--who leads product strategy for BoldChat, LogMeIn's live chat and multichannel customer engagement offering--will co-present a session titled, "When it Comes to Customer Engagement - Mobile Changes EVERYTHING" taking place today at 3:45 pm CST.
LOGM: 51.74 (+0.13)

CACI International Hits 52-Week High on Strong Q1 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 4:20PM CST
Shares of CACI International (CACI) hit a 52-week high of $84.08 on Nov 3, 2014. However, the stock closed the session at $83.69, which reflects a solid year-to-date return of 14.6%.
CARB: 11.63 (+0.22), LOGM: 51.74 (+0.13), CACI: 86.35 (+0.48), NCIT: 10.65 (-0.30)

LogMeIn to Discuss How to Create Connected Products that Transform Customer Engagement at Internet of @Things Expo
GlobeNewswire - Mon Nov 03, 8:35AM CST
LogMeIn's (Nasdaq:LOGM) Sean Lorenz, Technical Product Manager for the Xively IoT Platform, will be a featured speaker at Internet of @Things Expo, taking place November 4 - 6, 2014 in Santa Clara, California.
LOGM: 51.74 (+0.13)

CACI Comfortably Beats Q1 Earnings, Maintains FY15 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 11:10AM CDT
CACI International Inc (CACI) reported adjusted earnings of $43.6 million or $1.81 per share in the first quarter of fiscal 2015 versus $44.7 million or $1.80 per share in the prior-year quarter.
CSGS: 25.82 (+0.02), LOGM: 51.74 (+0.13), CACI: 86.35 (+0.48), INOD: 2.58 (-0.02)

Update: LogMeIn Tops Earnings Again For Q3
Marshall Hargrave - at Seeking Alpha - Thu Oct 30, 9:04AM CDT

LOGM: 51.74 (+0.13)

LogMeIn (LOGM) Upgraded From Hold to Buy
at The Street - Thu Oct 30, 8:39AM CDT
LogMeIn (LOGM) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-.
LOGM: 51.74 (+0.13)

SATO picks LogMeIn to enable IoT-connected printers
M2 - Thu Oct 30, 7:37AM CDT
LogMeIn (NASDAQ: LOGM) said that SATO has selected LogMeIn's Xively Internet of Things platform to build next-generation connectivity into its printers.
LOGM: 51.74 (+0.13)

SATO Selects LogMeIn to Enable Its Next Generation of IoT-Connected Printers
GlobeNewswire - Wed Oct 29, 8:00AM CDT
LogMeIn (Nasdaq:LOGM) today announced that SATO has selected LogMeIn's Xively Internet of Things (IoT) platform to build next-generation connectivity into its printers. SATO, a global provider of barcode printing, labeling, and EPC/RFID solutions, is also working with LogMeIn's IoT experts to maximize the business value of its IoT-connected products and accelerate their time to market. As a result, SATO anticipates a faster introduction of connected customer experiences across market segments, further differentiating its printer solutions against competitors, and lowering operational and support costs for its customers.
LOGM: 51.74 (+0.13)

LogMeIn's Strong Third Quarter Supports Bullish Long-Term View
Chris Katje - at Seeking Alpha - Mon Oct 27, 2:26PM CDT

LOGM: 51.74 (+0.13)

LogMeIn CMO, W. Sean Ford, to Participate in "Rise of the Empowered Customer" Roundtable Event
GlobeNewswire - Mon Oct 27, 8:00AM CDT
W. Sean Ford, Chief Marketing Officer of LogMeIn, Inc., (Nasdaq:LOGM) will be a featured speaker at the PAN Communications roundtable event, "Rise of the Empowered Customer," taking place on October 28, 2014 at the PAN Communications office. He will join a panel of leading marketing executives to discuss how they are positioning their organizations for success in a world driven by behavioral analytics that impact brands.
LOGM: 51.74 (+0.13)

LogMeIn reports Q3 2014 revenue up 35 percent YoY
M2 - Mon Oct 27, 6:26AM CDT
LogMeIn, Inc. (NASDAQ: LOGM) said its total third quarter 2014 revenue increased 35 percent to USD58.1 million from USD43.0 million reported in the third quarter of 2013.
LOGM: 51.74 (+0.13)

LogMeIn Named 2014 Boston Preservation Achievement Award Winner
GlobeNewswire - Fri Oct 24, 8:00AM CDT
LogMeIn, Inc. (Nasdaq:LOGM), has been named a winner of the 2014 Boston Preservation Achievement Awardsin recognition for the company's renovation and restoration of its corporate headquarters located at 320 Summer Street in Boston's Innovation District. The company's project was also voted the fan favorite 2014 Preservation Achievement Award winner by an online public vote.
LOGM: 51.74 (+0.13)

LogMeIn Q3 2014 revenue up 35% YoY
M2 - Fri Oct 24, 6:11AM CDT
LogMeIn, Inc. (NASDAQ: LOGM) said its total third quarter 2014 revenue increased 35 percent to $58.1 million from $43.0 million reported in the third quarter of 2013.
LOGM: 51.74 (+0.13)

LogMeIn Reports Third Quarter Results
Business Wire - Fri Oct 24, 5:00AM CDT
LogMeIn, Inc. (NASDAQ: LOGM) announced its results for the third quarter of 2014. Total revenue increased 35 percent to $58.1 million from $43.0 million reported in the third quarter of 2013.
LOGM: 51.74 (+0.13)

LogMeIn's (LOGM) CEO Michael Simon on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 23, 7:55PM CDT

LOGM: 51.74 (+0.13)

LogMein (LOGM) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 23, 3:55PM CDT

LOGM: 51.74 (+0.13)

LogMein beats by $0.04, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 3:17PM CDT

LOGM: 51.74 (+0.13)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Swanson Nexus Pro Launch: Boost for Dietitians

By Lucas Young Updated Oct 24, 2026 Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Love Business Group Helps SMEs Navigate Broadband Choices

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...